Stock Updates

How has CR Bard Inc.:(NYSE:BCR) performed recently?

CR Bard Inc. (NYSE: BCR) is a large market cap stock with a market cap of 16828.16. It is in the Medical Instruments & Supplies industry and sector Healthcare, with a current P/E of 44.17, a forward P/E of 19.79 and EPS of 5.06. At a stock price of 223.63 (3.10%) it has a dividend yield of 0.47%.

EPS growth for the last five years have been -19.80%, more recently this last year it has grown by -52.90%. The next year growth is going to be about 11.14% and more long-term 10.87% after five years. EPS growth quarter over quarter is 83.50%. Sales growth for the past five years have been 4.70% and sales growth quarter over quarter is -44.50%.

For performance, CR Bard Inc. the past week has seen a gain of 2.22%. For the last month performance for CR Bard Inc. is 2.22%. While the last quarter is -0.53% and half year, 15.72%. Finally for the year, performance is 15.28%.

The 52-week high for CR Bard Inc., is at -6.50%, and for the 52-week low it comes to a value of 30.33%. The 20-day simple moving average is -0.21% and 8.17% for the 200-day simple moving average.

Volatility for the week is at 2.24%, and for the month it is 1.34%. CR Bard Inc., has a target price of 243.83.

In terms of debt, long term debt/equity is 1.01, and for total debt/equity CR Bard Inc. has 1.01. The gross margin is 62.50%, while operating margin is 14.10%, the profit margin is 9.10%. The current ratio is 2.4 and the quick ratio is 1.9.

Insider ownership is at 0.20%, with instituitional ownership at 90.60%. CR Bard Inc. has a payout ratio of 22.00%. With the total shares outstanding coming to 75.25. The shares float is 73.31, with the float short at 1.94%, with short ratio coming to 3.19.

In terms of returns, the return on assets see CR Bard Inc., get 6.30%, with its returns on investment at 6.40%. Return on equity is 21.40%. So will the investors see the target price of 243.83, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment